CluePoints

We drive quality into Clinical Trials

  • Stage $1M in TTM Revenue
  • Industry Software
  • Location Mont-Saint-Guibert, Belgium
  • Currency EUR
  • Founded October 2012
  • Employees 25
  • Website cluepoints.com

Company Summary

CluePoints developed a unique – patent pending – software solution which is detecting anomalies into clinical trial data. From fraud to misunderstanding of protocols through the use of faulty devices.

Our potential market is made of 13,000 trials. In just two years the company grew from 5 to 25 people, generated 1.7m€ of growth earnings and is about to sign a collaborative agreement with FDA.

CluePoints is driving quality into clinical trials.

Team

  • Francois Torche

  • Patrick Hughes
    Chief Commercial Officer

    - 16 years of international experience
    - Previous experiences at an executive level at Greenphire, ERT and ClinPhone to lead global sales and marketing
    - Delivered double-digit growth

  • Marc Buyse
    Founder

    - Founder of IDDI and CluePoints
    - 35+ years of international experience
    - World-renowned biostatistician
    - Associate Professor of Biostatistics at the Universiteit Hasselt

Advisors

  • Pierre Rion
    Chairman
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free